Clinical Trial Materials Packaging & Labeling
DDL supports sponsors undertaking a wide range of clinical studies, from small open-label Phase 1 though large multi-center multi-national randomized, double-blind Phase 3 studies. All types of investigational products (IP) can be accommodated: orals, injectables, semi-solids, patches, etc., with labeling of primary packaging including bottles, vials, blister packs, sachets, and tubes. IP requiring special storage, e.g., cold or frozen, or handling, e.g., light sensitive, can be accommodated.